[{"data": {"name": "A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "G P Stathopoulos", "@type": "Person"}, {"name": "K Syrigos", "@type": "Person"}, {"name": "G Aravantinos", "@type": "Person"}, {"name": "A Polyzos", "@type": "Person"}, {"name": "P Papakotoulas", "@type": "Person"}, {"name": "G Fountzilas", "@type": "Person"}, {"name": "A Potamianou", "@type": "Person"}, {"name": "N Ziras", "@type": "Person"}, {"name": "J Boukovinas", "@type": "Person"}, {"name": "J Varthalitis", "@type": "Person"}, {"name": "N Androulakis", "@type": "Person"}, {"name": "A Kotsakis", "@type": "Person"}, {"name": "G Samonis", "@type": "Person"}, {"name": "V Georgoulias", "@type": "Person"}], "license": "cc-by-nc-sa", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc2360678?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1038/sj.bjc.6603301", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCLVaqToiut7R-CTCGfZznGMVvA-CDMozFm9hkegg-CRPkeuqt63KCt", "propertyID": "ISCC"}], "datePublished": "2006-08-08"}, "schema": "schema.org", "mediatype": "application/ld+json"}]